Erik Mills Schwiebert
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.2MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 20, 2021 | NIH | STTR Phase II Broad Spectrum Bitter Taste Antagonists Discovery | $21K | DISCOVERYBIOMED, INC. |
| Mar 30, 2021 | NIH | STTR Phase II Broad Spectrum Bitter Taste Antagonists Discovery | $765K | DISCOVERYBIOMED, INC. |
| May 10, 2019 | NIH | SBIR Phase II Humanized Kidney Cellular Toxicity Platforms | $552K | DISCOVERYBIOMED, INC. |
| May 9, 2019 | NIH | STTR Phase I Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery | $15K | DISCOVERYBIOMED, INC. |
| Aug 24, 2018 | NIH | STTR Phase I Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery | $271K | DISCOVERYBIOMED, INC. |
| Apr 22, 2018 | NIH | SBIR Phase II Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia | $385K | DISCOVERYBIOMED, INC. |
| Sep 22, 2017 | NIH | SBIR Phase II Humanized Kidney Cellular Toxicity Platforms | $206K | DISCOVERYBIOMED, INC. |
| Mar 31, 2016 | NIH | SBIR Phase II Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia | $366K | DISCOVERYBIOMED, INC. |
| Jul 2, 2015 | NIH | SBIR Phase II DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease | $632K | DISCOVERYBIOMED, INC. |
Peer ranks
Federal funding#553
Awards as PI#151
Patents#273
Companies
- DISCOVERYBIOMED, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.